A high‐sensitivity 10‐color flow cytometric minimal residual disease assay in B‐lymphoblastic leukemia/lymphoma can easily achieve the sensitivity of 2‐in‐106 and …
PR Tembhare, PG Subramanian PG… - Cytometry Part B …, 2020 - Wiley Online Library
Background Flow‐cytometric minimal residual disease (FC‐MRD) monitoring is a well‐
established risk‐stratification factor in B‐lymphoblastic leukemia/lymphoma (‐B‐ALL) and is …
established risk‐stratification factor in B‐lymphoblastic leukemia/lymphoma (‐B‐ALL) and is …
Evaluation of new markers for minimal residual disease monitoring in B‐cell precursor acute lymphoblastic leukemia: CD73 and CD86 are the most relevant new …
PR Tembhare, S Ghogale, N Ghatwai… - Cytometry Part B …, 2018 - Wiley Online Library
Background Multiparametric flow cytometry (MFC) is a popular technique for minimal
residual disease (MRD) analysis. However, its applicability is still limited to 90% of B‐cell …
residual disease (MRD) analysis. However, its applicability is still limited to 90% of B‐cell …
[HTML][HTML] Flow cytometric evaluation of CD38 expression levels in the newly diagnosed T-cell acute lymphoblastic leukemia and the effect of chemotherapy on its …
PR Tembhare, H Sriram, T Khanka… - … for Immunotherapy of …, 2020 - ncbi.nlm.nih.gov
Background Recently, anti-CD38 monoclonal antibody (Mab) therapy has become a focus of
attention as an additional/alternative option for many hematological neoplasms including T …
attention as an additional/alternative option for many hematological neoplasms including T …
A novel and easy F xCycle™ violet based flow cytometric method for simultaneous assessment of DNA ploidy and six‐color immunophenotyping
P Tembhare, Y Badrinath, S Ghogale, N Patkar… - Cytometry Part …, 2016 - Wiley Online Library
Abnormal DNA ploidy is a valuable prognostic factor in many neoplasms, especially in
hematological neoplasms like B‐cell acute lymphoblastic leukemia (B‐ALL) and multiple …
hematological neoplasms like B‐cell acute lymphoblastic leukemia (B‐ALL) and multiple …
Eleven‐marker 10‐color flow cytometric assessment of measurable residual disease for T‐cell acute lymphoblastic leukemia using an approach of exclusion
PR Tembhare, G Chatterjee, T Khanka… - Cytometry Part B …, 2021 - Wiley Online Library
Measurable/minimal residual disease (MRD) status has been suggested as a powerful
indicator of clinical‐outcome in T‐cell lymphoblastic leukemia/lymphoma (T‐ALL). Multicolor …
indicator of clinical‐outcome in T‐cell lymphoblastic leukemia/lymphoma (T‐ALL). Multicolor …
[HTML][HTML] Post-induction measurable residual disease using multicolor flow cytometry is strongly predictive of inferior clinical outcome in the real-life management of …
PR Tembhare, G Narula, T Khanka, S Ghogale… - Frontiers in …, 2020 - frontiersin.org
Background: Measurable/minimal residual disease (MRD) status is suggested as a powerful
indicator of clinical-outcome in T-cell lymphoblastic leukemia/lymphoma (T-ALL). Contrary to …
indicator of clinical-outcome in T-cell lymphoblastic leukemia/lymphoma (T-ALL). Contrary to …
[HTML][HTML] Critical role of flow cytometric immunophenotyping in the diagnosis, subtyping, and staging of T-cell/NK-cell non-Hodgkin's lymphoma in real-world practice: a …
Background T-cell/NK-cell non-Hodgkin's lymphoma (T/NK-NHL) is an uncommon
heterogeneous group of diseases. The current classification of T/NK-NHL is mainly based …
heterogeneous group of diseases. The current classification of T/NK-NHL is mainly based …
Comprehensive immune cell profiling depicts an early immune response associated with severe coronavirus disease 2019 in cancer patients
PR Tembhare, H Sriram, G Chatterjee… - … and Cell Biology, 2022 - Wiley Online Library
Recent studies have highlighted multiple immune perturbations related to severe acute
respiratory syndrome coronavirus 2 infection–associated respiratory disease [coronavirus …
respiratory syndrome coronavirus 2 infection–associated respiratory disease [coronavirus …
CD304/neuropilin‐1 is a very useful and dependable marker for the measurable residual disease assessment of B‐cell precursor acute lymphoblastic leukemia
P Gudapati, T Khanka, G Chatterjee… - Cytometry Part B …, 2020 - Wiley Online Library
Background Measurable residual disease (MRD) assessment using multicolor flow
cytometry (MFC) has become the center point of pediatric B‐cell precursor acute …
cytometry (MFC) has become the center point of pediatric B‐cell precursor acute …
15‐color highly sensitive flow cytometry assay for post anti‐CD19 targeted therapy (anti‐CD19‐CAR‐T and blinatumomab) measurable residual disease assessment …
G Chatterjee, P Dhende, S Raj, V Shetty… - European Journal of …, 2024 - Wiley Online Library
Objectives Measurable residual disease (MRD) is the most relevant predictor of disease‐
free survival in B‐cell acute lymphoblastic leukemia (B‐ALL). We aimed to establish a highly …
free survival in B‐cell acute lymphoblastic leukemia (B‐ALL). We aimed to establish a highly …